(Updated - February 18, 2026 7:12 AM EST)

TD Cowen analyst Charles Rhyee upgraded Medpace (NASDAQ: MEDP) from Sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE